Evidence map›Paper›PMID 39666958›Full record

ArticleThe Journal of urology2025

Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Jacob E Tallman, Emily A Vertosick, Syed M Alam, Fady J Baky, S Machele Donat, Eugene J Pietzak, Eugene K Cha, Timothy F Donahue, Bernard H Bochner, Andrew J Vickers and 1 more

Abstract read
In one paragraph

Article in The Journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Antimicrobial strategies for ureteral stent removal after radical cystectomy: a comparative cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Reply by Authors.The Journal of urology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jacob E TallmanDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Emily A VertosickDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Syed M AlamDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Fady J BakyDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
S Machele DonatDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Eugene J PietzakDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Eugene K ChaDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Timothy F DonahueDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Bernard H BochnerDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Andrew J VickersDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Alvin C GohDivision of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-3092-9024

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeUreteral stents are commonly placed intraoperatively during radical cystectomy, although their efficacy in reducing complications is unproven. We compared clinical outcomes among patients undergoing robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC) with or without ureteral stents to determine if omission of ureteral stents affects postoperative complications. MATERIALS AND

methodsAll RARC-IC surgeries performed at our institution between November 2017 and June 2023 were reviewed. Beginning August 2021, ureteral stents were routinely omitted. Primary outcome was ureteroenteric anastomosis complications (urine leak, UTI, abscess, and/or sepsis) within 30 and 90 days of RARC-IC. Secondary outcomes included rates of wound infections, urgent care center visits, inpatient readmissions, and ureteral stricture.

resultsAmong 133 patients included, 90 patients (68%) received a ureteral stent and 43 (32%) did not. Composite ureteroenteric anastomosis complications were higher in the stented group (20% vs 9.5%, 10% difference, 95% CI, -3.4% to 24%,

conclusionsOmission of ureteral stent placement at RARC-IC is safe and feasible. Randomized trials are warranted to determine the effects of stents on risk of postoperative complications after RARC-IC.

Indexed as

CystectomyPostoperative ComplicationsRobotic Surgical ProceduresStentsUreterUrinary Bladder NeoplasmsUrinary DiversionAgedFemaleHumansMaleMiddle AgedRetrospective Studiesbladder cancerpostoperative complicationsradical cystectomyrobot-assisted surgeryurinary diversion

Identifiers

PMID39666958
PMCPMC11888893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.